1. Improved contraceptive counselling needed with MTX use

   Epidemiology population study 11 May 2013 Pages: 1 - 1

2. Perioperative SSRI use increases risk of adverse outcomes

   Incidence study 11 May 2013 Pages: 1 - 1

3. Analgesics before endurance sport increase risk of adverse events

   Incidence study 11 May 2013 Pages: 2 - 2

4. At-home med errors common among kids with cancer

   Incidence study 11 May 2013 Pages: 2 - 2

5. Guillain-Barré syndrome not associated with vaccination

   Epidemiology population study 11 May 2013 Pages: 3 - 3

6. FDA warns of potential confusion with name of new cancer drug

   News item 11 May 2013 Pages: 3 - 3

7. Azithromycin and CV mortality risk in a general population

   Epidemiology population study 11 May 2013 Pages: 3 - 3

8. Vigibase grows to 8 million reports

   Media release 11 May 2013 Pages: 4 - 4

9. Propylthiouracil use and serious skin reactions

   Incidence study 11 May 2013 Pages: 4 - 4

10. EMA provides first details of its reorganisation

    Media release 11 May 2013 Pages: 4 - 4

11. EMA publishes list of meds under close watch

    Media release 11 May 2013 Pages: 4 - 4

12. Pradaxa label warns of stroke risks following discontinuation

    Media release 11 May 2013 Pages: 4 - 4

13. Alemtuzumab

    Case report 11 May 2013 Pages: 5 - 5

14. Adalimumab

    Case report 11 May 2013 Pages: 5 - 5

15. 4-amino-3-phenylbutyric acid

    Case report 11 May 2013 Pages: 5 - 5

16. Adefovir dipivoxil

    Case report 11 May 2013 Pages: 5 - 5

17. Amiodarone

    Case report 11 May 2013 Pages: 6 - 6

18. Amiodarone

    Case report 11 May 2013 Pages: 6 - 6

19. Alteplase

    Case report 11 May 2013 Pages: 6 - 6

20. Antineoplastics

    Case report 11 May 2013 Pages: 7 - 7

21. Amodiaquine/artesunate

    Case report 11 May 2013 Pages: 7 - 7

22. Antiretrovirals/warfarin interaction

    Case report 11 May 2013 Pages: 7 - 7

23. Amlodipine

    Case report 11 May 2013 Pages: 7 - 7

24. Amphotericin B

    Case report 11 May 2013 Pages: 7 - 7

25. Amiodarone

    Case report 11 May 2013 Pages: 7 - 7

26. Arsenic trioxide

    Case report 11 May 2013 Pages: 8 - 8

27. Aspirin

    Case report 11 May 2013 Pages: 8 - 8

28. Antituberculars

    Case report 11 May 2013 Pages: 8 - 8

29. Asparaginase

    Case report 11 May 2013 Pages: 8 - 8

30. Aripiprazole/risperidone

    Case report 11 May 2013 Pages: 8 - 8

31. Aspirin withdrawal

    Case report 11 May 2013 Pages: 9 - 9

32. Atorvastatin/ranolazine interaction

    Case report 11 May 2013 Pages: 9 - 9

33. Atorvastatin

    Case report 11 May 2013 Pages: 9 - 9

34. Aspirin/warfarin

    Case report 11 May 2013 Pages: 9 - 9

35. Atropine/homatropine/phenylephrine

    Case report 11 May 2013 Pages: 10 - 10

36. BCG vaccine

    Case report 11 May 2013 Pages: 10 - 10

37. BCG

    Case report 11 May 2013 Pages: 10 - 10

38. Bleomycin

    Case report 11 May 2013 Pages: 11 - 11

39. Bevacizumab

    Case report 11 May 2013 Pages: 11 - 11

40. Bevacizumab/erlotinib

    Case report 11 May 2013 Pages: 11 - 11

41. Bevacizumab

    Case report 11 May 2013 Pages: 11 - 11

42. Bupropion

    Case report 11 May 2013 Pages: 12 - 12

43. Bleomycin

    Case report 11 May 2013 Pages: 12 - 12

44. BV NSCLC 001

    Case report 11 May 2013 Pages: 12 - 12

45. Bromocriptine

    Case report 11 May 2013 Pages: 12 - 12

46. Capecitabine/lapatinib

    Case report 11 May 2013 Pages: 13 - 13

47. Calcium carbonate/valsartan/hydrochlorothiazide/vitamin D

    Case report 11 May 2013 Pages: 13 - 13

48. Capsaicin

    Case report 11 May 2013 Pages: 13 - 13

49. Carbamazepine

    Case report 11 May 2013 Pages: 14 - 14

50. Cetuximab

    Case report 11 May 2013 Pages: 14 - 14